Phathom Pharmaceuticals Appoints Dr. James Topper to its Board of Directors
FLORHAM PARK, N.J., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing...
Month: September 2022
Secure Transfusion Solutions Announces it will Present New Data and Participate at the 2022 AABB Annual Meeting
AUSTIN, Texas, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Secure Transfusion Solutions (STS), a private life sciences company pioneering innovative solutions...
Erasca to Present at the Bank of America Securities Precision Oncology Conference 2022
SAN DIEGO, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on...
Gain Therapeutics Presents New Preclinical Data Showing Promising Pharmacological Activity in Parkinson’s Disease Patient-Derived Dopaminergic Neurons
Accumulating Preclinical Data Provide Further Support for Disease-Modifying Potential of Brain Penetrant Investigational Small Molecule Therapeutic, GT-02287 Results Presented at...
Immutep to Participate in Two Upcoming Investor Conferences
SYDNEY, AUSTRALIA, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage...
Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment from Petrichor
~ Under the Terms of the Previously Announced Investment Agreement, $5 Million Already Funded Upon Initial Closing, Which Occurred on...
Theratechnologies to Announce Third Quarter 2022 Financial Results and Provide Business Update
MONTREAL, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a biopharmaceutical company focused on the...
Relay Therapeutics to Participate in Fireside Chat at Bank of America Securities 2022 Precision Oncology Conference
CAMBRIDGE, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the...
BioLife Sciences Inc. (OTC: BLFE) Enters Into Negotiations for Exclusive Licensing Deal With Canadian Firm
HENDERSON, NV, Sept. 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioLife Sciences (OTCPK: BLFE) is pleased to announce that...
Cytokinetics Announces Upcoming Presentations at the 2022 Inaugural HCM Society Scientific Sessions and the HFSA Annual Scientific Meeting
Two Late Breaking Clinical Trials Sessions to Feature New Data from REDWOOD-HCM OLESOUTH SAN FRANCISCO, Calif., Sept. 26, 2022 (GLOBE...
Intellia Therapeutics to Present at October Healthcare Investor Conferences
CAMBRIDGE, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on...
Simply Better Brands Corp.’s PureKana Brand, Growing 362% vs Year Ago, Completes Its Wholesale Distribution Expansion Into Four Large U.S. Markets
As PureKana broadens route to market, it expands the portfolio to innovate beyond CBD into a wellness brand addressing diverse...
People impacted due to Hurricane Fiona are asked to register with Canadian Red Cross
Registration with Red Cross ensures people can be notified as services may become availableOTTAWA, Sept. 25, 2022 (GLOBE NEWSWIRE) --...
Canadian Red Cross launches appeal for Hurricane Fiona
Hurricane Fiona causes catastrophic damage across five Canadian provinces.OTTAWA, Sept. 24, 2022 (GLOBE NEWSWIRE) -- The Canadian Red Cross has...
With 48% of pregnancies being unintentional, let’s talk about contraception options
World Contraception Day What is available? How to talk contraception with a physician or your partner?OTTAWA, Ontario, Sept. 24, 2022...
Palisade Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Carlsbad, CA, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute...
Adverum Biotechnologies to Participate in the Jefferies Cell and Genetic Medicine Summit
REDWOOD CITY, Calif., Sept. 23, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to...
PDS Biotech Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FLORHAM PARK, N.J., Sept. 23, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a...
New Study Reveals Effective Treatment for Children Suffering From Persistent Post-Concussion Syndrome
Study shows that hyperbaric oxygen therapy significantly improves symptoms, including memory, emotional and behavioral, and heals brain structure in cortical...
InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
VANCOUVER, British Columbia, Sept. 23, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader...